Search for: "State v. L. A. T." Results 9141 - 9160 of 9,945
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas),… [read post]
25 Jul 2008, 2:11 am
    In keeping with the flexible nature of the obviousness inquiry, KSR Int'l Co. v. [read post]
22 Jul 2008, 7:51 pm
In keeping with the flexible nature of the obviousness inquiry, KSR Int'l Co. v. [read post]
20 Jul 2008, 4:15 am
How can one expect a state like that to hold together? [read post]
19 Jul 2008, 1:09 am
Sherman in his Texas State & Local Tax Law BlogAlso worth noting: Fox Rothschild attorney Francis G.X. [read post]
18 Jul 2008, 8:34 am
– Considering settlement: Cognitive biases when conducting risk analysis: (The IP ADR Blog), WIPO enriched by in-depth discussions of the public domain: (KEI), WIPO Committee on Development and IP ends first year on mostly agreeable note: (Intellectual Property Watch), Implementation of WIPO Committee on Development and IP agenda moves forward: (WIPO), (Intellectual Property Watch), (Managing Intellectual Property), WIPO Committee on Development and IP deliberations on norm-setting, open… [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge),  (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]